HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos H Schenck Selected Research

nelotanserin

1/2021Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos H Schenck Research Topics

Disease

10REM Sleep Behavior Disorder
01/2022 - 04/2010
6Parasomnias (Parasomnia)
01/2022 - 06/2007
5Narcolepsy
01/2022 - 05/2013
5Parkinson Disease (Parkinson's Disease)
01/2022 - 12/2009
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 12/2009
4Dementia (Dementias)
01/2022 - 04/2010
4Somnambulism (Sleepwalking)
01/2021 - 08/2012
3Nervous System Diseases (Neurological Disorders)
01/2022 - 11/2009
3Obstructive Sleep Apnea
01/2021 - 01/2016
2Sleep Wake Disorders
01/2022 - 12/2010
2Mental Disorders (Mental Disorder)
01/2022 - 11/2009
2Mood Disorders (Mood Disorder)
01/2022 - 11/2021
2Synucleinopathies
01/2020 - 01/2018
2Feeding and Eating Disorders (Eating Disorder)
10/2018 - 08/2012
2Parkinsonian Disorders (Parkinsonism)
08/2013 - 12/2009
2Restless Legs Syndrome (Restless Legs)
08/2012 - 06/2010
2Sleep Initiation and Maintenance Disorders (Insomnia)
08/2012 - 05/2003
1Cocaine-Related Disorders (Cocaine Addiction)
01/2022
1Neoplasms (Cancer)
01/2022
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022
1Stroke (Strokes)
01/2022
1Chronic Disease (Chronic Diseases)
01/2021
1Idiopathic Hypersomnia
01/2021
1Wounds and Injuries (Trauma)
01/2020
1Occupational Stress
10/2018
1Multiple System Atrophy
01/2018
1Nocturnal Paroxysmal Dystonia
06/2017
1Cognitive Dysfunction
08/2013
1Schizophrenia (Dementia Praecox)
01/2011
1Autistic Disorder (Autism)
01/2011
1Alzheimer Disease (Alzheimer's Disease)
04/2010
1Seizures (Absence Seizure)
06/2007
1Hyperkinesis
05/2003

Drug/Important Bio-Agent (IBA)

8Clonazepam (Rivotril)FDA LinkGeneric
04/2020 - 06/2007
4Pharmaceutical PreparationsIBA
01/2022 - 01/2013
3Antidepressive Agents (Antidepressants)IBA
01/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2020
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2021 - 12/2008
1alpha-SynucleinIBA
01/2022
1nelotanserinIBA
01/2021
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1AdderallIBA
01/2021
1Bupropion (Wellbutrin)FDA LinkGeneric
01/2021
1MelatoninIBA
04/2020
1Sertraline (Zoloft)FDA LinkGeneric
10/2018
1neodymium pyrocatechin disulfonate (NPD)IBA
06/2017
1Complement System Proteins (Complement)IBA
03/2014
1Neuroprotective AgentsIBA
08/2013
1Hypnotics and Sedatives (Sedatives)IBA
08/2012
1Anesthetics (Anesthetic Agents)IBA
01/2011
1IronIBA
06/2010
1Rivastigmine (Exelon)FDA LinkGeneric
04/2010
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2010
1Anticonvulsants (Antiepileptic Drugs)IBA
06/2007
1OrexinsIBA
05/2003

Therapy/Procedure

13Therapeutics
01/2022 - 06/2007
5Continuous Positive Airway Pressure
01/2021 - 06/2007
3Drug Therapy (Chemotherapy)
01/2021 - 11/2009
1Hypnosis (Mesmerism)
01/2017